Literature DB >> 25242227

Redox regulation of botulinum neurotoxin toxicity: therapeutic implications.

Mauricio Montal1.   

Abstract

Botulinum neurotoxin causes botulism, and the only effective antidote is the antitoxin. Botulinum neurotoxins are disulfide linked di-chain proteins encompassing a light chain Zn2+-protease that is translocated by a heavy chain channel from the synaptic vesicle lumen into the neuronal cytosol where it acts. Protease release from the channel is required for toxicity. The Thioredoxin Reductase-Thioredoxin system cleaves the interchain disulfide, and its inhibition prevents neurotoxicity, and may provide novel strategies for chemoprophylaxis and therapy.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  SNAREs; botulism; channel; chaperone; protease; thioredoxin

Mesh:

Substances:

Year:  2014        PMID: 25242227      PMCID: PMC4253726          DOI: 10.1016/j.molmed.2014.09.005

Source DB:  PubMed          Journal:  Trends Mol Med        ISSN: 1471-4914            Impact factor:   11.951


  10 in total

Review 1.  Botulinum neurotoxin: a marvel of protein design.

Authors:  Mauricio Montal
Journal:  Annu Rev Biochem       Date:  2010       Impact factor: 23.643

2.  Crucial role of the disulfide bridge between botulinum neurotoxin light and heavy chains in protease translocation across membranes.

Authors:  Audrey Fischer; Mauricio Montal
Journal:  J Biol Chem       Date:  2007-07-31       Impact factor: 5.157

3.  Bimodal modulation of the botulinum neurotoxin protein-conducting channel.

Authors:  Audrey Fischer; Yuya Nakai; Lisa M Eubanks; Colin M Clancy; William H Tepp; Sabine Pellett; Tobin J Dickerson; Eric A Johnson; Kim D Janda; Mauricio Montal
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-21       Impact factor: 11.205

4.  Botulinum neurotoxin type A is internalized and translocated from small synaptic vesicles at the neuromuscular junction.

Authors:  Cesare Colasante; Ornella Rossetto; Laura Morbiato; Marco Pirazzini; Jordi Molgó; Cesare Montecucco
Journal:  Mol Neurobiol       Date:  2013-03-08       Impact factor: 5.590

Review 5.  Botulinum neurotoxins: genetic, structural and mechanistic insights.

Authors:  Ornella Rossetto; Marco Pirazzini; Cesare Montecucco
Journal:  Nat Rev Microbiol       Date:  2014-06-30       Impact factor: 60.633

6.  Neutralizing human monoclonal antibodies binding multiple serotypes of botulinum neurotoxin.

Authors:  C Garcia-Rodriguez; I N Geren; J Lou; F Conrad; C Forsyth; W Wen; S Chakraborti; H Zao; G Manzanarez; T J Smith; J Brown; W H Tepp; N Liu; S Wijesuriya; M T Tomic; E A Johnson; L A Smith; J D Marks
Journal:  Protein Eng Des Sel       Date:  2010-12-13       Impact factor: 1.650

7.  Iterative structure-based peptide-like inhibitor design against the botulinum neurotoxin serotype A.

Authors:  Jorge E Zuniga; Jared T Hammill; Omri Drory; Jonathan E Nuss; James C Burnett; Rick Gussio; Peter Wipf; Sina Bavari; Axel T Brunger
Journal:  PLoS One       Date:  2010-06-30       Impact factor: 3.240

Review 8.  The thioredoxin antioxidant system.

Authors:  Jun Lu; Arne Holmgren
Journal:  Free Radic Biol Med       Date:  2013-07-27       Impact factor: 7.376

Review 9.  Thioredoxins, glutaredoxins, and peroxiredoxins--molecular mechanisms and health significance: from cofactors to antioxidants to redox signaling.

Authors:  Eva-Maria Hanschmann; José Rodrigo Godoy; Carsten Berndt; Christoph Hudemann; Christopher Horst Lillig
Journal:  Antioxid Redox Signal       Date:  2013-03-28       Impact factor: 8.401

10.  Thioredoxin and its reductase are present on synaptic vesicles, and their inhibition prevents the paralysis induced by botulinum neurotoxins.

Authors:  Marco Pirazzini; Domenico Azarnia Tehran; Giulia Zanetti; Aram Megighian; Michele Scorzeto; Silvia Fillo; Clifford C Shone; Thomas Binz; Ornella Rossetto; Florigio Lista; Cesare Montecucco
Journal:  Cell Rep       Date:  2014-09-15       Impact factor: 9.423

  10 in total
  3 in total

Review 1.  On botulinum neurotoxin variability.

Authors:  Cesare Montecucco; Maria Berica Rasotto
Journal:  mBio       Date:  2015-01-06       Impact factor: 7.867

Review 2.  Toxicology and pharmacology of botulinum and tetanus neurotoxins: an update.

Authors:  Marco Pirazzini; Cesare Montecucco; Ornella Rossetto
Journal:  Arch Toxicol       Date:  2022-03-25       Impact factor: 6.168

3.  A Novel Inhibitor Prevents the Peripheral Neuroparalysis of Botulinum Neurotoxins.

Authors:  Domenico Azarnia Tehran; Giulia Zanetti; Oneda Leka; Florigio Lista; Silvia Fillo; Thomas Binz; Clifford C Shone; Ornella Rossetto; Cesare Montecucco; Cristina Paradisi; Andrea Mattarei; Marco Pirazzini
Journal:  Sci Rep       Date:  2015-12-16       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.